ci 934 has been researched along with vancomycin in 3 studies
Studies (ci 934) | Trials (ci 934) | Recent Studies (post-2010) (ci 934) | Studies (vancomycin) | Trials (vancomycin) | Recent Studies (post-2010) (vancomycin) |
---|---|---|---|---|---|
33 | 0 | 2 | 16,808 | 773 | 7,589 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gottschall, S; Kim, MJ; Randall, EL; Weiser, M | 1 |
Finch, R; Martin, J; Pilkington, R | 1 |
Floyd-Reising, SA; Hindler, JA; Kelley, SG; Young, LS | 1 |
3 other study(ies) available for ci 934 and vancomycin
Article | Year |
---|---|
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecalis; Erythromycin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Quinolines; Streptococcus; Thienamycins; Vancomycin | 1987 |
In vitro assessment of CI-934--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1986 |
In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Quinolines; Vancomycin | 1987 |